Júlia Sala

Ms. Júlia Sala


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2020 in Cells
Verified
Journal Article
Open access
PDF file
JSJúlia Sala
Júlia Sala
FVFrancina Mesquida Veny
Francina Mesquida Veny
MBMaider Badiola-Mateos
Maider Badiola-Mateos
Josep Samitier MartíJosep Samitier Martí
Josep Samitier Martí
Arnau HerveraArnau Hervera
Arnau Hervera
José Antonio Del Río FernándezJosé Antonio Del Río Fernández
José Antonio Del Río Fernández
Peripheral nerve injuries, including motor neuron axonal injury, often lead to functional impairments. Current therapies are mostly limited to surgical intervention after lesion, yet these interventions have limited success in restoring functionality. Current activity-based therapies after axonal injuries are based on trial-error approaches in which the details of the underlying cellular and molecular processes are largely unknown. Here we show the effects of the modulation of both neuronal and muscular activity with optogenetic approaches to assess the regenerative capacity of cultured motor neuron (MN) after lesion in a compartmentalized microfluidic-assisted axotomy device. With increased neuronal activity, we observed an increase in the ratio of regrowing axons after injury in our peripheral-injury model. Moreover, increasing muscular activity induces the liberation of leukemia inhibitory factor and glial cell line-derived neurotrophic factor in a paracrine fashion that in turn triggers axonal regrowth of lesioned MN in our 3D hydrogel cultures. The relevance of our findings as well as the novel approaches used in this study could be useful not only after axotomy events but also in diseases affecting MN survival.

Verified
Journal Article
Open access
PDF file
JSJúlia Sala
Júlia Sala
KZKarolina Zimkowska
Karolina Zimkowska
JAJesus Avila
Jesus Avila
Isidro FerrerIsidro Ferrer
Isidro Ferrer
José Antonio Del Río FernándezJosé Antonio Del Río Fernández
José Antonio Del Río Fernández
Tauopathies are a group of neurodegenerative diseases characterized by the hyperphosphorylation and deposition of tau proteins in the brain. In Alzheimer’s disease, and other related tauopathies, the pattern of tau deposition follows a stereotypical progression between anatomically connected brain regions. Increasing evidence suggests that tau behaves in a “prion-like” manner, and that seeding and spreading of pathological tau drive progressive neurodegeneration. Although several advances have been made in recent years, the exact cellular and molecular mechanisms involved remain largely unknown. Since there are no effective therapies for any tauopathy, there is a growing need for reliable experimental models that would provide us with better knowledge and understanding of their etiology and identify novel molecular targets. In this review, we will summarize the development of cellular models for modeling tau pathology. We will discuss their different applications and contributions to our current understanding of the “prion-like” nature of pathological tau.

Verified
Journal Article
Open access
PDF file
Isidro FerrerIsidro Ferrer
Isidro Ferrer
PBPol Andrés Benito
Pol Andrés Benito
PGPaula Garcia-Esparcia
Paula Garcia-Esparcia
ILIrene López-Gonzalez
Irene López-Gonzalez
DVDiego Valiente
Diego Valiente
José Antonio Del Río FernándezJosé Antonio Del Río Fernández
José Antonio Del Río Fernández
Alzheimer’s disease (AD) and other tauopathies are common neurodegenerative diseases in older adults; in contrast, abnormal tau deposition in neurons and glial cells occurs only exceptionally in children. Sarkosyl-insoluble fractions from sporadic AD (sAD) containing paired helical filaments (PHFs) were inoculated unilaterally into the thalamus in newborn and three-month-old wild-type C57BL/6 mice, which were killed at different intervals from 24 h to six months after inoculation. Tau-positive cells were scanty and practically disappeared at three months in mice inoculated at the age of a newborn. In contrast, large numbers of tau-positive cells, including neurons and oligodendrocytes, were found in the thalamus of mice inoculated at three months and killed at the ages of six months and nine months. Mice inoculated at the age of newborn and re-inoculated at the age of three months showed similar numbers and distribution of positive cells in the thalamus at six months and nine months. This study shows that (a) differences in tau seeding between newborn and young adults may be related to the ratios between 3Rtau and 4Rtau, and the shift to 4Rtau predominance in adults, together with the immaturity of connections in newborn mice, and (b) intracerebral inoculation of sAD PHFs in newborn mice does not protect from tau seeding following intracerebral inoculation of sAD PHFs in young/adult mice.

1 June 2022 in Nanomedicine
Verified
Journal Article
Closed access
JSJúlia Sala
Júlia Sala
EGElisa García-Lara
Elisa García-Lara
PCPaula Carreras-Domínguez
Paula Carreras-Domínguez
CZChunfang Zhou
Chunfang Zhou
NRNeus Rabaneda-Lombarte
Neus Rabaneda-Lombarte
JSJosep Saura
Josep Saura
Aim: Mesoporous silica particles (MSPs) are broadly used drug delivery carriers. In this study, the authors analyzed the responses to MSPs of astrocytes and microglia, the two main cellular players... Plain language summary Mesoporous silica particles (MSPs) are broadly used drug delivery carriers. In this study, the authors analyzed the responses of two types of brain cells, astrocytes and micr... Graphical abstract

3 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
ALAndrew P. Longhini
Andrew P. Longhini
MFMara Fattah
Mara Fattah
JSJúlia Sala
Júlia Sala
ADAustin DuBose
Austin DuBose
ERErica Keane Rivera
Erica Keane Rivera
KKKenneth S. Kosik
Kenneth S. Kosik
The misfolding, aggregation, and spread of tau protein fibrils underlie tauopathies, a diverse class of neurodegenerative diseases for which effective treatments remain elusive. Among these are corticobasal dementia (CBD) and progressive supranuclear palsy (PSP), canonical examples of 4-repeat (4R) tauopathies characterized by tau isoforms exclusively with four microtubule-binding repeat domains. We target this 4R tau isoform-specific mechanism by focusing on misfolded tau’s distinctive stem-loop-stem structural motif formed by the junction of the 4R-defining alternatively spliced exon and the adjacent constitutive exon. A synthetic peptide based on this stem-loop-stem sequence can induce aggregation and spread in an isoform-specific manner. Here, we develop a protein-like polymer (PLP) in which multiple copies of this synthetic peptide form a brush-like structure capable of preventing tau aggregation by binding and capping fibril ends in vitro , in human brain organoids, and in cellular models with an EC50 of 105 ± 14 nM. PLPs demonstrate robust activity against fibrils derived from CBD and PSP patient brains and a PS19 mouse tauopathy model. Previous tau-targeted treatments have primarily focused on broad tau clearance, aggregation inhibition, or microtubule stabilization, often lacking isoform specificity and precision. In contrast, this approach targets the 4R tau isoform’s unique structural motif, offering a tailored therapeutic intervention for diseases like CBD and PSP. Supported by prior studies showing blood-brain barrier penetrance and safety profiles, this tau-binding PLP offers a promising translational path toward clinical applications in tauopathy treatment.

1 December 2025 in Review of Scientific Instruments
Verified
Journal Article
Closed access
ZZZongren Zhang
Zongren Zhang
TMTjitse Van der Molen
Tjitse Van der Molen
CCCarolina Maciel Camargo
Carolina Maciel Camargo
MMMarkus W. Merk
Markus W. Merk
MKMookwang Kwon
Mookwang Kwon
PHPaul Hansma
Paul Hansma
We present a custom recording platform that enables electrophysiological recordings with Neuropixels 2.0 from human brain and heart organoids by maintaining a stable, physiological environment of 5% CO2, 37 °C, and 95% relative humidity. The platform combines a modular positioning system with real-time camera guidance for precise probe alignment. We validated the system by recording consistent bursting activity in brain organoids over a 110-min period and in heart organoids for up to 11 h.